Loading
Led INTERLACE, which showed a short course of chemotherapy before chemoradiation cuts cervical cancer deaths using cheap, available drugs.
Mary McCormack was chief investigator of INTERLACE, the international trial showing six weeks of induction carboplatin and paclitaxel before standard chemoradiotherapy improves progression-free and overall survival in locally advanced cervical cancer, a result immediately implementable in low-resource settings where most cervical cancer occurs. She leads gynaecological radiotherapy research at UCLH.
Shares INTERLACE, Brachytherapy, Cervical cancer, Carboplatin.
Shares British Journal of Cancer, Paclitaxel / nab-paclitaxel.
Shares Paclitaxel / nab-paclitaxel, Carboplatin and the tag chemoradiotherapy.
Shares Cervical cancer and the tag cervical.
Shares Cervical cancer and the tag cervical.
Shares Brachytherapy, Cervical cancer, IMRT / IGRT (modern external beam).
Shares Cervical cancer and the tag cervical.
Shares Brachytherapy, Cervical cancer.